Fed. Circ. Largely Backs Generics In Suboxone Patent Fight
The Federal Circuit ruled Friday that generic versions of the opioid addiction treatment Suboxone marketed by Dr. Reddy's and Alvogen do not infringe patents held by Indivior, but that a Teva...To view the full article, register now.
Already a subscriber? Click here to view full article